Nefense Launches Hypochlorous Acid Nasal Spray Line for Age-Specific Airway Hygiene

Nefense®, a leader in advanced clinical hygiene and airway health solutions, today announced the official launch of its Hypochlorous Acid (HOCl) nasal spray line, expanding its portfolio to include age-specific formulations for adults, children, and infants. The new product line, highlighted by the flagship Hyponasal spray, delivers a gentle yet effective biocleanse designed to flush irritants, provide soothing relief, and support natural respiratory defenses without harsh chemicals or steroids.

The launch addresses a growing need for safe and effective nasal care across all age groups. Hypochlorous acid, the active ingredient, offers broad-spectrum antimicrobial and anti-inflammatory action that neutralizes bacteria and viruses, helps prevent upper respiratory infections, and combats seasonal allergies. By tailoring the formulations to different age brackets, Nefense ensures optimal safety and efficacy for each demographic, from infants with sensitive airways to adults seeking robust respiratory protection.

According to the company, the Hyponasal spray is powered by HOCl, a substance naturally produced by the human immune system. This makes it a gentle yet powerful option for maintaining airway hygiene. The product is designed to be used as part of a daily hygiene routine, helping to reduce the risk of infections and manage allergy symptoms. The age-specific approach reflects Nefense's commitment to bridging the gap between daily hygiene, airway health, restorative sleep, and overall wellness.

Nefense has collaborated with doctors and ENT specialists to develop these solutions. Many clinics and practices nationwide already offer in-store purchases of the Nefense nasal spray family, including XyloClean, a xylitol-based nasal spray that moisturizes and rebalances nasal passages. The new HOCl line extends this portfolio, providing consumers with more options for respiratory care.

The implications of this launch are significant for public health. By offering a non-pharmaceutical, clinically inspired approach to airway hygiene, Nefense provides an accessible tool for reducing the burden of upper respiratory infections and allergies. This is particularly important in a post-pandemic world where respiratory health remains a top priority. The age-specific formulations also address a market gap, as many nasal sprays are not suitable for young children or infants, leaving caregivers with limited options.

For more details, the full announcement is available here. Nefense continues to develop advanced, science-driven health and hygiene products, working with medical professionals to ensure their offerings meet high standards of safety and efficacy. The company's commitment to helping people breathe better and live healthier is evident in this latest product expansion.